Mikkel Holm Vendelbo
VIP, Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (20)
Herpes simplex encephalitis (HSE) is a devastating disease with high mortality and serious sequelae. Genetic defects in the IFN-I pathway predispose individuals to HSE, but underlying mechanisms remain unclear. Using transgenic mice with the IRF3 R278Q mutation, ortholog to HSE-associated IRF3 R285Q, and iPSC-derived CNS cells from a pediatric patient carrying the variant, we investigated mechanisms in HSE. IRF3 R278Q transgenic mice exhibited aggravated HSV-1 brain disease and elevated CNS viral loads. Accordingly, microglia from the IRF3 R278Q mice showed reduced HSV-1–induced IFN-I expression. Surprisingly, unaltered Ifnb levels along with elevated levels of inflammatory cytokines were detected in infected transgenic mouse brains, correlating with higher viral load. This was successfully modeled in patient microglia. Multiomics-based immune profiling revealed an inflammatory monocyte population in the infected IRF3 R278Q mouse brain, which was enriched for NF-κB activation. NF-κB inhibition improved disease outcomes, surpassing the effect of acyclovir. These findings suggest that IFN-I defects lead to elevated levels of HSV-1 replication in the brain, which subsequently enables NF-κB–driven immunopathology, offering insights with therapeutic potential.
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Objectives Vascular graft or endograft infections (VGEIs) pose a detrimental complication when using vascular grafts and are challenging to diagnose and treat. This study examined the progression of infection and the antimicrobial response in VGEI using [18F]Fluorodeoxyglucose (chemical name, 2-Deoxy-2-[18F]fluoroglucose) (FDG) positron emission tomography (PET), ex vivo bacterial quantification, and histology in a VGEI rat model. Methods In this experimental study, 97 male Sprague–Dawley rats had a polytetrafluorethylene graft surgically implanted in the carotid artery. The graft was either preinoculated with Staphylococcus aureus, S. epidermidis, or saline. Up to 31 days after surgery, rats were FDG-PET-scanned. Subsequently, they were killed, and the implants were retrieved for analysis. A subgroup of infected rats received daptomycin and rifampicin from days 20 to 29. Results Tracer uptake around the implant, measured by maximum standardized uptake value (SUVmax), declined over time in all groups. Between groups, SUVmax was highest in untreated S. aureus-infected rats. When comparing antibiotic-treated and uninfected rats by day 31, there was no difference in SUVmax, although the treated rats were still infected. Histology revealed widespread inflammation by day 10 in S. aureus-infected rats, which decreased by days 20 and 31 with encapsulation of the infection, alongside increased plasma interleukin-10. Conclusions FDG-PET differentiated untreated S. aureus-infected rats from uninfected ones but failed to monitor infection progression, as SUVmax declined over time despite a constant bacterial load. FDG-PET could not distinguish between uninfected rats and those with suppressed infection, likely due to reduced inflammation and encapsulation of the infection.
Year:
2026
Year:
2026
Year:
2026
Background and purpose: Quantification/mapping of tumor hypoxia may guide pretreatment decision-making in radiation oncology. Hypoxia-selective positron emission tomography (PET) tracers, like 18F-fluoroazomycin arabinoside (FAZA), allow assessment of hypoxia, but since hypoxia stimulates glycolysis, fluorodeoxyglucose (FDG) and hypoxia-PET may provide overlapping/similar information. Clinical dual-tracer PET studies are highly complex and remain inconclusive. Accordingly, we developed dual-tracer autoradiography techniques to allow high-resolution assessment of the spatial coupling of FAZA and 14C-2DG (FDG-analogue), without the time-separation and co-registration-related inaccuracies intrinsic to PET. Patient/material and methods: Orthotopic lung adenocarcinomas were induced in CRISPR/Cas9 knock-in mice. Mammary adenocarcinomas developed spontaneously in transgenic mice overexpressing ErbB2 (Her2). Patient-derived-xenografts (PDX) were established in immunocompromised mice using biopsies from oropharyngeal cancer patients. Tumor growth was followed by MRI/Caliper measurements. Mice were administered with FAZA (~40 MBq)/14C-2DG (37 kBq)/pimonidazole and sacrificed. Tumor cryosections were analyzed for FAZA/14C-2DG using dual-tracer autoradiography followed by histological stainings. Complementary autoradiograms were co-registered and covered by a square-grid (0.5 × 0.5 mm), and Pearson correlation coefficients (R) were calculated. Results/Interpretation: Hypoxic sub-volumes (FAZA/pimonidazole) were commonly present. A reasonable spatial overlap between FAZA and 14C-2DG was observed in most lung and oropharyngeal tumors with R typically exceeding 0.55. In the breast tumor model, the extent of overlap between FAZA and 14C-2DG varied widely with R ranging from 0.03 to 0.82, which may relate to intertumor mutational differences in this Her2+ oncogene-driven model. Our results suggest a putative role for FDG-PET to identify hypoxic foci and guide dose-escalation.
Year:
2025
Background The axolotl is a prominent model organism of heart regeneration due to its ability to anatomically and functionally repair the heart after an injury that mimics human myocardial infarction. In humans, such an injury leads to permanent scarring. Cardiac regeneration has been linked to metabolism and the oxygenation state, but so far, these factors remain to be detailed in the axolotl model. In this descriptive study, we have investigated metabolic changes that occurred during cardiac regeneration in the axolotl. Results We describe systemic and local cardiac metabolic changes after injury involving an early upregulation of glucose uptake and nucleotide biosynthesis followed by a later increase in acetate uptake. We detect several promising factors and metabolites for future studies and show that, unlike other popular animal models capable of intrinsic regeneration, the axolotl maintains its cardiac regenerative ability under hyperoxic conditions. Conclusions Axolotls undergo dynamic metabolic changes during the process of heart regeneration and display a robust reparative response to cardiac cryo‐injury, which is unaffected by hyperoxia.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Collaborators (59)
Stefanie Fruhwürth
Group leader
University of Gothenburg
Karin Dedek
Adjunct Professor
Carl von Ossietzky Universität Oldenburg
Niels Peter Revsbech
Professor
Aarhus University
Niels Jessen
Head of Research
Aarhus University
Johanne Ahrenfeldt
Aarhus University
Coen P. H. Elemans
Professor
University of Southern Denmark
Signe Borgquist
VIP, Clinical Professor and Chair
Aarhus University
Jacob Kinggaard Lilja-Fischer
DVIP-part-time lecturer, Part-time Lecturer
Aarhus University
Michael Horsman
Professor
Aarhus University
Anne Kruse Hollensen
Aarhus University
Trine Ørhøj Barkholt
Aarhus University
Laura Teodori
ETH Zürich
Hans Zischka
Technical University of Munich
Kirstine Lykke Nielsen
VIP, Associate Professor
Aarhus University
Niels Bassler
VIP, Professor
Aarhus University
Christian Staehr
DVIP-part-time lecturer, Part-time Lecturer
Aarhus University
Jianhai Du
West Virginia University
Ole Lajord Munk
Professor of Medical Physics
Aarhus University
Mads Kjolby
Aarhus University Hospital
Thomas Baad-Hansen
VIP, Clinical Professor
Aarhus University
Johan Palmfeldt
VIP, Associate Professor
Aarhus University
Line Reinert
VIP, Associate Professor
Aarhus University
Asger Andersen
VIP, Associate Professor
Aarhus University
Rasmus Bak
VIP, Associate Professor
Aarhus University
Christian Damsgaard
VIP, Associate Professor
Aarhus University
Jeremy Semrau
University of Michigan
Hans‐Christian Beck
Senior Researcher
Odense University Hospital
Lars Christian Gormsen
VIP, Clinical Professor and Chair
Aarhus University
André H. Dias
VIP, Clinical Associate Professor
Aarhus University
Jesper Skovhus Thomsen
VIP, Professor
Aarhus University
Thomas Damgaard Sandahl
VIP, Clinical Professor
Aarhus University
Frederik Teicher Kirk
Aarhus University
Per Bendix Jeppesen
Associate Prof, PhD
Aarhus University
Joanna Kalucka
Assistant Professor
Aarhus University
Aage Kristian Olsen Alstrup
VIP, Associate Professor
Aarhus University
Søren Baarsgaard Hansen
VIP, Associate Professor
Aarhus University
Thomas Mejer Hansen
VIP, Associate Professor
Aarhus University
Martin Thomsen
VIP, Associate Professor
Aarhus University
Valentina Medici
Professor
University of California, Davis
Mariana Bresque
University of Wisconsin-Madison
Johan Bussink
Radboud University Medical Center
Cecilie Bay-Richter
Associate Professor
Aarhus University
Tina Myhre Pedersen
Aarhus University
Ebbe Boedtkjer
VIP, Professor
Aarhus University
Roberta Leonardi
West Virginia University
Michelle Møhlenberg
Aarhus University
Kasper Hansen
Tenure Track Assistant Professor
Aarhus University
Elena E. Ferapontova
Assoc. Professor
Aarhus University
Sebastian Nielsen
Aarhus University
Vladimir V. Matchkov
Professor
Aarhus University
Lars Thrane
Aarhus University
Trine Hyrup Mogensen
DVIP-external, Professor
Aarhus University
Søren Degn
VIP, Associate Professor
Aarhus University
Henrik Lauridsen
VIP, Associate Professor
Aarhus University
Michael Pedersen
VIP, Professor
Aarhus University
Niels Henrik Buus
Aarhus University Hospital
Christian Stald Skoven
Aarhus University
Rikke Louise Meyer
Professor
Aarhus University
Lars Poulsen Tolbod
Associate Professor
Aarhus University
Make your next move.
Prepare your application
Review drafts before you send them.